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DIABETIC FOOT SYNDROME – DERMATOlOgICAl 
pOINT OF vIEw
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SUMMARY – patients with diabetes mellitus often suffer from diabetic foot syndrome, a con-
dition leading to foot ulceration or even amputation of lower extremity. peripheral neuropathy com-
bined with repetitive trauma to the foot and peripheral vascular disease are the main etiological 
factors in the development of foot ulcers. Other major contributive factors include the effects of 
callus, increased plantar pressures, and local infections. patient education concerning their disease 
has a central role in the prevention of foot ulcers. Ordinary preventive measures taken by the pati-
ent include regular self-inspections, appropriate daily hygiene of the feet, appropriate footwear to 
reduce plantar pressures, and medical pedicure performed by a pedicurist experienced in diabetic 
foot patients. The importance of callus in diabetic patients has been shown in several studies by high 
predictability of subsequent ulcer development in patients with plantar calluses. For removing callus, 
urea based preparations are considered to be the treatment of choice. In case of local bacterial and 
fungal diabetic foot infections, systemic antibiotic and systemic antimycotic therapy is indicated, 
respectively. wound dressings of various types are the mainstay in the treatment of chronic foot 
ulcers with avoidance of occlusive dressings in infected ulcers. Since the vast majority of ulcers and 
amputations can be prevented in diabetic patients, proper diagnosis and multidisciplinary approach 
are essential. 
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Introduction 
patients with diabetes mellitus are known to be 
prone to many serious complications in the course of 
their disease. One of the most devastating of these 
conditions is certainly the diabetic foot syndrome 
(DFS), which is the leading cause of nontraumatic 
lower extremity amputations in developed countries1. 
The combination of peripheral neuropathy and re-
petitive trauma is the essential part in the complex 
pathophysiological mechanism that ultimately leads 
to foot ulceration2. whereas in normal skin the ulcer 
caused by physical trauma heals relatively rapidly under 
appropriate conditions, in diabetics the healing pro-
cess is impaired and therefore significantly prolonged 
(Fig. 1). Foot ulcer affects one of six diabetic patients 
during the course of their disease3. Furthermore, ap-
proximately 20% of diabetic patients with foot ulcers 
also have underlying osteomyelitis, whereby the fore-
foot (metatarsal head and distally) is the involved site 
in 90% of cases4. The average onset of foot ulceration 
in diabetic patients is about 14 years after the initial 
diagnosis of diabetes mellitus and the amputation 
rate in western countries is 2.5-6 per 1000 patients 
per year5. Diabetics as opposed to nondiabetics also 
have a 15- to 46-fold greater risk of lower extremity 
amputation1 and 20- to 50-fold greater risk of gan-
grene5. Finally, economic costs of treating foot ulcers 
in patients with diabetes mellitus are enormous6. The 
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fact that foot ulcerations can be prevented in the great 
majority of diabetic patients with an estimated 85% of 
amputations preventable, highlights the importance 
of appropriate foot care, the use of appropriate foot-
wear and patient education in this condition1,7. 
Pathophysiology of Diabetic Foot Syndrome
Diabetic foot can be classified according to the ex-
tent of lesion, from stage 0 with no visible defect to the 
skin, to stage 5 with gangrene of the whole foot (Table 
1)1. peripheral neuropathy is considered to have a cen-
tral role in the development of DFS, acting together 
with repetitive physical trauma, usually due to inap-
propriate footwear2,7. Other important pathophysio-
logical components include vascular micro- and mac-
roangiopathy, deformity of the foot, and especially the 
formation of callus5,7. Noticeably, almost two-thirds 
of foot ulcer patients have concomitantly trauma, de-
formity and neuropathy7. 
Some diabetic patients develop the so-called 
Charcot neuroarthropathy, an inflammatory syn-
drome characterized by varying degrees of bone and 
joint destruction, fragmentation and remodeling, ul-
timately leading to bone fractures as well as to sub-
sequent deformity, large ulcers and infection5,8,9. This 
condition usually involves the tarsus but can also af-
fect the metatarsus and can ultimately lead to amputa-
tion5. According to published data, the prevalence of 
Charcot foot syndrome among diabetic patients varies 
from 0.15% to 6.8%9. 
Role of Neuropathy in the Pathogenesis of 
Diabetic Foot Syndrome
The central role of neuropathy in the development of 
foot ulceration in patients with diabetes mellitus is due 
to its three main types: sensory, motor and autonomic10. 
Sensory neuropathy renders the foot insensitive to pain, 
temperature, vibration and pressure10. The gradual loss 
of protective sensitivity, which includes sensitivity to 
pain and temperature, leads to further reduction in the 
perception of pain stimuli9. Therefore, the lesions that 
would otherwise be noticed in a healthy person, can 
escape notice up to the point of severe necrosis lasting 
for a number of weeks in diabetic patients5. Typical fea-
tures of sensory neuropathy also include a symmetric, 
stocking-like loss of sensation, as well as diminished 
patellar and Achilles tendon reflexes5. 
Motor neuropathy is another crucial component of 
peripheral neuropathy that contributes to the develop-
ment of foot ulceration. The contributive mechanism 
of motor neuropathy is the weakening of interosseous 
and lumbrical muscles within the foot, causing ab-
normal flexion of the toes and foot deformation, thus 
leading to the formation of areas of high plantar pres-
sure, especially beneath the metatarsal heads and 
toes5,9. According to gefen11, plantar pressure under 
the first metatarsal head was four times higher in dia-
betic patients compared to nondiabetics and almost 
eight times higher on the second metatarsal head. 
Forefoot to ground contact increases by 38% under 
the first metatarsal head and by 50% under the sec-
ond metatarsal head. It was also shown that pressures 
within the internal plantar soft tissues rose even more 
significantly: by 82% and 307% under the first and 
second metatarsal heads, respectively11. This patho-
logical increase in plantar pressures as a final conse-
quence of motor neuropathy is clearly associated with 
the development of foot ulceration, as it was shown 
in a prospective study in which plantar ulceration 
occurred in 35% of diabetic patients with high foot 
pressures, while there was no plantar ulcer recorded 
in patients with normal plantar pressure12. peripheral 
motor neuropathy in diabetic patients also causes al-
tered gait with a prolonged support time, thus further 
aggravating plantar pressures and increasing the risk 
of developing foot ulcerations13. 
The third, autonomic component of peripheral 
neuropathy causes vasodilatation and anhidrosis that 
Fig. 1. Diabetic foot ulcer. 
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leads to the impairment of vascular circulation and 
skin perspiration. As a result, the skin becomes dry, 
therefore more susceptible to multiple minor physical 
traumas, infections, as well as to subsequent forma-
tion of callus5,10. 
Importance of Callus in the Development of 
Diabetic Foot Ulcer
According to Dorland’s Medical Dictionary, cal-
lus is defined as localized hyperplasia of the stratum 
corneum of the epidermis due to pressure or friction14. 
Although of special importance in diabetic patients, 
callus is very common in otherwise healthy, nondia-
betic individuals. According to a published report by 
Sage et al.15, 82.4% of diabetic patients with foot ulcer 
have previously had callus formation. Another report 
by Murray et al.16 found a relative risk of 11.0 for an ul-
cer developing under an area of callus in a neuropathic 
diabetic foot, showing plantar callus to be highly pre-
dictive of subsequent ulcer development. The high-
est relative risk (56.8) involved the sites of previous 
ulceration16. Clinically, callus is seen as a thickened, 
hyperkeratotic plaque with little or no ability of pain 
perception5. This particular feature of callus only 
worsens the already present peripheral neuropathy in 
diabetic patients, making them less able to sense pain 
or early signs of inflammation14. Due to its thickened 
structure, callus increases pressure on the underlying 
tissues, contributing to new lesion formation, thus 
creating a vicious cycle. Increased mechanical pres-
sure finally separates the nonelastic callus from un-
derlying tissue creating skin tears and blisters, which 
form the basis of an ulcerative lesion5. The develop-
ment of ulcer within the callus region may be accom-
panied by surrounding inflammation whose symp-
toms are easily overlooked since the typical signs of 
inflammation such as erythema, warmth or swelling 
occur in the plantar region, which has a particularly 
thickened stratum corneum14. In addition to that, dia-
betic patients with sensory neuropathy have a lack of 
pain sensation, which allows further development of 
callus, progressive tissue destruction, and ultimately 
ulcer formation5. For this reason, new techniques for 
detecting early signs of inflammation have recently 
been used, as reported by Nishide et al.14 in their cross-
sectional study of 60 patients with asymptomatic foot 
callus (30 diabetic patients as opposed to 30 nondia-
betics). The study used thermography and ultrasonog-
raphy to detect signs of inflammation that could not 
be identified by physical examination performed by 
wound care specialists. latent inflammatory changes 
were found by both techniques in 10% of the calluses 
in diabetic group, while no inflammation was noted 
in nondiabetic group of patients (inflammation was 
defined as skin temperature elevation on thermogra-
phy and hypoechoic lesion on ultrasonography). The 
results suggested a high risk of ulceration in diabetic 
group of patients having asymptomatic foot callus, as 
well as the use of thermography and ultrasonography 
as the possible effective diagnostic tools in the preven-
tion of inflammation14.
Vascular Disease in Patients with Diabetic Foot 
Syndrome
vascular pathology is a common complication in 
diabetic patients and it affects all types of blood ves-
sels. peripheral vascular disease (pvD) is considered 
to play a significant role in the development of DFS 
and diabetic foot ulceration, and the risk of suffering 
from pvD in diabetic patients is approximately four-
fold compared to nondiabetics, with a 5 to 10 years 
earlier onset in diabetics5,17. various reports from the 
USA, UK and Finland have confirmed the signifi-
cance of pvD in the pathogenesis of foot ulceration 
and have also shown pvD to be a major risk factor for 
subsequent foot amputations10. According to a study 
by pataky et al.18, related to diabetic patients with both 
peripheral neuropathy and peripheral vascular disease, 
pvD contributes to an increase in plantar pressures as 
well as to a prolonged foot to floor walking contact. 
In such patients, severe ischemia increases the risk of 
foot ulceration and amputation, especially when com-
bined with local foot infection18,19. Concomitant ar-
terial hypertension and/or hyperlipidemia in diabetic 
patients, as well as tobacco smoking increase particu-
larly the risk of developing peripheral artery disease 
(pAD), which can be classified according to Fontaine 
into four stages: pAD without subjective symptoms 
(stage I), presence of intermittent claudication (stage 
II), ischemic pain at rest, including pain at night 
(stage III), and ischemic ulceration or gangrene of the 
foot (stage Iv)1. preventive and therapeutic measures 
for pvD therefore include firstly and most impor-
tantly good glycemic regulation, cessation of smok-
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ing, physical activity, appropriate treatment of other 
diseases that contribute to the progression of pvD, 
eventually thrombolytic and antiaggregation medica-
tions, and revascularization as early as Fontaine stage 
II, as well as newer techniques such as percutaneous 
interventions20,21. 
Infections of Diabetic Foot
patients with diabetes mellitus are especially vul-
nerable to foot infections due to the effects of periph-
eral neuropathy and peripheral vascular disease22. 
Sensory neuropathy causes the patient to be insensi-
tive to minor trauma, which in case of diabetic patients 
mostly occurs during walking due to inappropriate 
footwear. Motor neuropathy causes deformities of the 
foot making it even more vulnerable to injury. Finally, 
autonomic neuropathy causes dry skin as well as other 
trophic changes of the skin and nails, thereby signifi-
cantly impairing the barrier functions of the skin5. All 
these factors combined create a favorable environment 
for the invasion and colonization of microorganisms 
into the superficial and deeper tissues of the foot. The 
resolution of such an infection in diabetic patients is 
further compromised by the same mechanisms that 
caused the infection, as well as by diabetic vascular in-
sufficiency22. Clinically, foot infection can be defined 
as the presence of two or more local signs of infection 
(erythema, warmth, pain, edema), or the presence of 
purulent secretion or the presence of systemic signs 
of infection7. Furthermore, a number of scoring sys-
tems have been developed for assessing foot ulceration 
and infection22. These include, for example, wagner 
score23, which classifies the wound according to the 
depth and severity of ulceration, regardless of etiol-
ogy. A more useful classification system for clinical 
practice may be that of the Infectious Diseases Soci-
ety of America (IDSA) that ranks infected wounds 
as mild, moderate or severe, which allows clinicians 
to assess therapy and diagnostics needed for treating 
the patient22. 
Once an infection has been diagnosed, further 
clinical and microbiological findings are necessary 
in determining the causative pathogens for the pur-
pose of instigating appropriate and efficacious ther-
apy. The nature and duration of the lesion itself is a 
valuable lead for that purpose. Recently developed, 
superficial ulcers for which no therapy has been used 
so far are most likely to harbor aerobic gram-positive 
cocci, such as Staphylococcus aureus22. On the other 
side of the spectrum, chronic, persistent ulcers that 
have often extended into deeper tissues and usually 
have already had extensive antimicrobial therapy are 
a much greater diagnostic and therapeutic challenge, 
as they are more likely to harbor more than one kind 
of bacteria22. These often include both gram-positive 
and gram-negative cocci, as well as various kinds of 
therapy resistant microbes. For an accurate and clini-
cally relevant microbiological analysis, it is important 
to take into account the indigenous microbial flora of 
the skin, which naturally interferes with the patho-
logic flora, complicating the interpretation of swab 
culture findings. Adequate debridement of the lesion 
and swab culture or even biopsy from the base of the 
lesion is crucial for proper analysis and clinical inter-
pretation22. 
Fungal Infections in Diabetic Foot Syndrome
Fungal infections play a crucial role in the develop-
ment and course of foot infections in diabetic patients 
since their influence is twofold. Fungi act as infectious 
agents themselves, contributing to the pathogenesis of 
foot ulceration, while at the same time, they facilitate 
bacterial infections5. The prevalence of fungal infec-
tions in diabetic foot patients as well as specific fungal 
pathogens isolated in such patients varies considerably. 
According to Mayser et al.24, 82.1% of 95 patients with 
type 1 diabetes mellitus had clinical signs of dermato-
mycosis or onychomycosis and 84.6% of these patients 
tested positive microscopically or by culture. In this 
study, the most commonly isolated fungal pathogen 
was the dermatophyte Trichophyton rubrum. Other 
studies performed by Eckhardt et al.25 and Romano 
et al.26 have also found Trichophyton rubrum to be the 
most common pathogen. Contrary to these findings, 
a number of other studies have demonstrated Candida 
spp. to be the most commonly isolated fungal species in 
diabetic foot patients27. Fata et al., for example, found 
a 20% prevalence of fungal infections in diabetic foot 
patients, caused mainly by various species of Candida 
spp., especially Candida albicans26. Mlinarić-Missoni 
et al.28 report on Candida parapsilosis as the most fre-
quent causative agent in diabetic foot ulcers, followed 
by seven other Candida species. They also found pure 
fungal infections in only one-third of patients, while 
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the other two-thirds had a mixed fungal-bacterial 
infection. The majority of patients with mixed infec-
tions (80% of patients) presented also with a more se-
vere clinical picture, which may partly be explained 
by a greater ability of Candida spp. to cause infec-
tions when acting together with other microorgan-
isms28. Characteristic of diabetic foot ulcers are also 
infections caused by otherwise low pathogenic yeasts, 
many of which are part of the normal mycobiotic flora 
of the skin28. Certain mold species, i.e. Aspergillus 
spp., Fusarium spp., Penicillium spp. and Scopolariopsis 
spp., have also been found in patients with diabetic 
foot ulcers27. Another important factor in the develop-
ment and course of fungal infections is the influence 
of certain therapeutic measures that are common in 
diabetic foot patients. This includes topical applica-
tion of antibiotics, especially when combined with the 
often prescribed measure of long wrapping of the foot. 
Thus, choosing the proper antibiotic requires compli-
ance with therapy guidelines, as well as an individual-
ized approach to the patient. The resulting increased 
temperature and sweating of the skin, as well as the 
immunomodulating influence of antibiotics, increases 
the number of yeasts in the affected area28. Because 
of the complex nature and often chronic duration of 
the lesion, systemic antifungal therapy is considered 
to be the treatment of choice for diabetic patients with 
fungal ulcer infection. 
Treatment of Patients with Diabetic Foot 
Syndrome
prevention of foot ulcerations is the main goal of 
treatment for diabetic patients with a high risk of de-
veloping DFS. For that part, patient education in both 
prevention and prompt treatment of a newly occurred 
lesion plays a fundamental role. Overall, preventive 
measures include regulation of diabetes, hypertension 
and hyperlipidemia, as well as a regulated physical ac-
tivity and cessation of smoking29. patients also have to 
be educated in performing appropriate hygiene, pref-
erably daily washing of the feet, daily self-inspection, 
wearing appropriate footwear, including shoe inlay 
devices that would reduce plantar pressures, i.e. cor-
rect the biomechanical abnormalities for the purpose 
of redistributing increased plantar pressures from par-
ticular portions of the foot onto the whole foot. As for 
the maintenance of foot care, i.e. pedicure, the patient 
has to inform the pedicurist of their diabetic condition 
in order to apply appropriate medical pedicure, since 
an incompetent pedicure can cause lesions leading 
to chronic ulcers in diabetic patients. For removing 
callus, various preparations containing urea are the 
treatment of choice. These include urea moisturizers 
with concentrations of 10% to 40%5. The main effect 
of such urea preparations is twofold: reducing tran-
sepidermal water loss and keratolysis without reactive 
activation of basal cells30,31. Keratolysis prevents the 
formation of callus or leads to its removal, which fur-
ther reduces plantar pressure, ultimately preventing 
foot ulceration since an elevated plantar pressure is a 
known risk factor for the development of foot ulcers12. 
The keratolytic effect of urea is furthermore important 
when dealing with frequently occurring dermatomy-
cosis and/or onychomycosis in diabetic foot patients. 
The required topical antimycotic therapy for such pa-
tients is severely impaired by the presence of callus 
or other forms of hyperkeratotic, scaly skin, which 
prevents adequate absorption of the antifungal agent. 
Here, the combination of topical antimycotics with 
urea containing preparations, preferably in higher 
concentrations, i.e. 40%, can significantly increase the 
absorption and the efficacy of the topical antimycotic, 
as it was shown in the case of moccasin type tinea pe-
dis patients in the study by Elewski et al.32. Contrary 
to urea preparations, any topical preparation contain-
ing salicylic acid should be avoided, since there is a 
greater risk of injury to nerve fibers and blood vessels 
in patients with DFS. 
Once a foot ulcer has occurred, closure of the le-
sion as swift as possible becomes the main objective 
of treatment. Due to the complex etiology of diabetic 
foot ulcer, as well as various comorbidity associated 
with diabetes mellitus, a multidisciplinary approach 
is essential. This includes a combined diabetologic, 
surgical and dermatologic expertise. Surgical debride-
ment of necrotic tissue and removal of callus is usually 
the first step in foot ulcer therapy, accompanied by 
appropriate systemic antibiotic therapy and, in case of 
a proven fungal infection, systemic antimycotic ther-
apy. wound dressings are, further on, an important 
part of managing diabetic ulcers. Here, the experi-
ence in treating chronic wounds is most valuable in 
choosing the appropriate dressing among the various 
types that exist. In general, occlusive dressings should 
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not be applied to infected diabetic foot ulcers, since 
occlusion worsens the infection, as mentioned above. 
Infected ulcers in particular often have a heavy exu-
date, thus requiring dressings with a greater absorp-
tion capacity, such as foam and alginate dressings33. 
various dressings containing silver are also often used 
for infected wounds, since the antimicrobial actions 
of silver include direct inhibition of bacterial cell res-
piration, inactivation of intracellular enzymes, and al-
terations to the cell membrane33. Necrotic ulcers, for 
example, respond well to hydrogels due to their ability 
of autolysis33. Any type of dressing, however, should 
Fig. 2. Malignant melanoma ulcer on the foot of a diabetic 
patient.
Table 1. Classification of diabetic foot according to the extent of ulceration1
Stage 0 No visible ulcerations, foot deformities, or sensation disorder present. 
Stage 1A Superficial ulcerations without cellulitis or signs of infection.
Stage 1B Ischemia in addition to superficial ulcerations. No cellulitis or signs of infection.
Stage 2A Deep ulcerations until the tendon, bone and ligaments or joint capsule. No signs of infection. Sensation disorder present.
Stage 2B Ischemia in addition to deep ulcerations until the tendon, bone and ligaments or joint capsule. No signs of infection. Sensation disorder present.
Stage 3A Deep ulcerations with abscess formation or signs of osteomyelitis. Signs of comprehensive cellulitis and systemic intoxication, loss of sensation, foot deformities. 
Stage 3B vascular disturbances in addition to deep ulcerations with abscess formation or signs of osteomyeli-tis. Signs of comprehensive cellulitis and systemic intoxication, loss of sensation, foot deformities. 
Stage 4
gangrene of the toes accompanied by cellulitis and systemic intoxication. Deep ulcerations with 
bones exposed accompanied by severe peripheral vascular disease. Complete loss of sensation. Sur-
gical intervention and revascularization needed. 
Stage 5 gangrene of the whole foot. Surgical revascularization or amputation needed.
be frequently changed and the wound inspected. In 
summary, an ‘ideal’ wound dressing should facilitate 
wound healing, reduce pain, and at the same be cost 
effective and comfortable for the patient. Not to ignore 
are also non-antimicrobial agents for the treatment of 
diabetic foot ulcers, such as human skin equivalents 
(Dermagraft, Apligraf) or the recombinant human 
platelet-derived growth factor20,34. Finally, all health 
care providers involved in the treatment of foot lesions 
in diabetic patients should be aware of the possibil-
ity of other nondiabetic pathologic conditions, such as 
skin or soft tissue cancers, arising within the primary 
diabetic lesion (Fig. 2). Hence the importance of fre-
quent and careful inspection of foot ulcers in diabetic 
patients, as to avoid improper or negligent treatment. 
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Sažetak
SINDROM DIJABETIČNOg STOpAlA – DERMATOlOŠKO glEDIŠTE
N. Troskot, T. Duvančić i M. Kolić
Bolesnici s dijabetes melitusom često pate od sindroma dijabetičnog stopala, stanja koje dovodi do stvaranja ulkusa 
na stopalu ili čak do amputacije donjeg ekstremiteta. periferna neuropatija udružena s ponavljajućom traumom stopala, 
te periferna vaskularna bolest su glavni etiološki čimbenici u nastanku ulkusa stopala. Drugi značajno doprinoseći čim-
benici uključuju utjecaj kalusa, povećani plantarni pritisak i lokalne infekcije. Središnju ulogu u prevenciji ulkusa stopala 
ima izobrazba bolesnika o njihovoj bolesti. Jednostavne preventivne mjere koje bolesnik može poduzeti uključuju redovite 
samopreglede, odgovarajuću dnevnu higijanu stopala, odgovarajuću obuću radi smanjenja plantarnih pritisaka te medi-
cinsku pedikuru koju treba provoditi pediker s iskustvom u obradi bolesnika s dijabetičnim stopalom. važnost kalusa kod 
dijabetičnih bolesnika je pokazana u nekoliko studija s obzirom na veliku vjerojatnost naknadnog nastanka ulkusa kod 
bolesnika s plantarnim kalusima. U svrhu odstranjenja kalusa terapija izbora su pripravci na bazi ureje. U slučaju lokalne 
bakterijske ili gljivične infekcije dijabetičnog stopala indicirana je sistemska antibiotska, odnosno sistemska antimikotična 
terapija. Različite vrste obloga za rane su stožerna terapija za kronične ulkuse stopala uz izbjegavanje okluzivnih zavoja 
kod inficiranih ulkusa. S obzirom na to da se velika većina ulkusa i amputacija kod dijabetičnih bolesnika može spriječiti, 
neophodna je ispravna dijagnostika i multidisciplinarni pristup. 
Ključne riječi: Sindrom dijabetičnog stopala; Ulkus stopala; Neuropatija; Vaskulopatija; Kalus; Infekcije rane; Izobrazba bo-
lesnika 
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